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Acinetobacter baumannii is a Gram-negative coccobacillus
found primarily in hospital settings that has recently emerged
as a source of hospital-acquired infections. A. baumannii
expresses a variety of virulence factors, including type IV pili,
bacterial extracellular appendages often essential for attachment to host cells. Here, we report the high resolution structures
of the major pilin subunit, PilA, from three Acinetobacter
strains, demonstrating that A. baumannii subsets produce morphologically distinct type IV pilin glycoproteins. We examine
the consequences of this heterogeneity for protein folding and
assembly as well as host-cell adhesion by Acinetobacter. Comparisons of genomic and structural data with pilin proteins from
other species of soil gammaproteobacteria suggest that these
structural differences stem from evolutionary pressure that has
resulted in three distinct classes of type IVa pilins, each found in
multiple species.

Type IV pili are extracellular adhesive appendages primarily
comprising a single protein subunit, called the major pilin,
which is assembled into a narrow (⬃6 –9-nm) helical fiber of
variable length (up to 2.5 m) (1). One or more other proteins,
called minor pilins, are also incorporated into the fiber at low
levels. All pilins contain an N-terminal signal sequence followed by an ⬃30-amino acid hydrophobic ␣-helix resembling a
transmembrane domain (the ␣1-N domain). This is, in turn,
followed by a soluble ⬃15-kDa globular domain referred to as
the pilin headgroup; the hydrophobic helical regions are buried
together in the center of the fiber, whereas portions of the
C-terminal headgroup are exposed (2, 3).
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Type IV pili are found in both Gram-negative (4, 5) and
Gram-positive (6 – 8) bacteria as well as Archea (9). They are
involved in a wide range of processes, including twitching
motility (10), horizontal gene transfer (11), host-cell adhesion
(12), and microcolony/biofilm formation (13). This functional
diversity is reflected in the sequence of the pilin proteins that
typically have little or no sequence identity beyond the hydrophobic portion of the N-terminal ␣-helix. This lack of sequence
identity is apparent even in cases where there is high structural
similarity.
In contrast, within a given species, the minor pilins are typically well conserved. Only the major pilin is highly variable
(14 –16) and then only in those regions left exposed in the
assembled pilus (17). This sequence diversity may result from
diversifying selection as a mechanism by which to avoid detection by the host immune system (18). However, such diversity
can also be found in species whose life cycle is primarily environmental (19). Glycosylation is an additional source of variability in some type IV pilins; O-linked glycosylation has been
observed in multiple strains of both Pseudomonas aeruginosa
(20 –22) and Neisseria (23, 24). Additional glycosylation sites
have been found in class II strains of Neisseria meningitidis
where they have been hypothesized to play a role in immune
evasion (25).
Among the many genera of Gram-negative bacteria that
express type IV pili is Acinetobacter, a coccobacillus that is
widely distributed in nature and can be isolated from the environment in the soil and in water as well as from a variety of
mammalian hosts (26, 27). Several species of Acinetobacter,
chiefly Acinetobacter baumannii, Acinetobacter calcoaceticus,
Acinetobacter nosocomialis, and Acinetobacter pittii, are collectively referred to as the A. calcoaceticus-baumannii (Acb)4
complex and constitute an increasingly common source of nosocomial infections (28 –30). Although reports of infections by
A. baumannii predominate in the literature, phenotypic similarity makes it difficult to differentiate between related Acineto-

4

The abbreviations used are: Acb, A. calcoaceticus-baumannii; MBP, maltosebinding protein; Bis-Tris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol; MPD, 2-methyl-2,4-pentanediol; PAK, P. aeruginosa
strain K; OTase, oligosaccharyltransferase; r.m.s.d., root mean square
deviation.
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bacter species (31), and in model organisms, all four species
have been found to be infectious (32).
Like other Acinetobacter species, A. baumannii lacks flagella
but exhibits twitching motility, which is dependent on type IV
pili (33). Type IV pili are also required for its natural transformation (33, 34), but their role in other biological processes is
unclear. Virstatin, a known inhibitor of type IV pilus formation
in Vibrio cholerae, was shown to both reduce type IV pilus
expression and inhibit biofilm formation in A. baumannii (35).
In another study, no correlation could be demonstrated
between antigenic variation in the A. baumannii major pilin,
pilA, and biofilm formation in vitro (36). More recently, Oh and
Choi (37) reported that deletion of a LuxR-type regulator,
AnoR, reduces both biofilm formation and surface motility in
A. nosocomialis ATCC 17903. In addition to variation in the
sequence of pilA, some Acinetobacter strains utilize an O-oligosaccharyltransferase to specifically glycosylate the major
pilin at a C-terminal serine with the major capsule polysaccharide repeat unit (38, 39). These post-translational modifications
are independent of the more general protein O-glycosylation
system common to many gammaproteobacteria (including
P. aeruginosa and Dichelobacter nodosus) (40 – 43). However,
Harding et al. (38) reported that pilin C-terminal glycosylation
is not required for either competence or twitching motility.
To understand the basis for the variability in sequence and
glycosylation of Acinetobacter PilA, we have resolved the x-ray
crystal structures of the major type IV pilin from three members of the Acb complex, strains ACICU and BIDMC 57 of
A. baumannii and strain M2 of A. nosocomialis. In these three
structures, we observe structural divergence independent of
species within Acinetobacter. We demonstrate that Acinetobacter type IV pili promote host-cell adhesion in a manner independent of C-terminal glycosylation. We also provide evidence
that the structural variation of Acinetobacter pilins is underpinned by functional differentiation.

Experimental Procedures
Protein Expression and Purification—Codon-optimized
sequences of PilA from A. baumannii ACICU and A. nosocomialis M2, starting with alanine 23, were cloned into a pETM44
vector with an N-terminal His6 tag. These clones were transformed into BL21 (DE3) pLysS cells and grown to saturation
overnight with shaking at 37 °C in LB medium with 50 g/ml
ampicillin. These saturation cultures were then diluted into
fresh LB-ampicillin and grown to an optical density (OD) of
0.4 – 0.6 at 37 °C. These flasks were transferred to a refrigerated
orbital shaker and cooled to 18 °C before induction with 30 mM
isopropyl ␤-D-1-thiogalactopyranoside. These flasks were
allowed to grow overnight before being harvested by centrifugation at 7500 ⫻ g for 10 min. The cells were then lysed using
lysozyme (0.25 mg/ml final concentration) for 10 min, and the
resulting lysate was centrifuged again, this time at 20,000 ⫻ g
for 30 min. The supernatant was purified using a nickel-nitrilotriacetic acid column, and the elution was further purified by
size exclusion chromatography over a GE Healthcare S200
Superdex column using an ÅKTA Purifier FPLC.
For crystallization, MBP-PilAACICU, MBP-PilABIDMC57, and
MBP-PilAM2 were cloned and expressed as described previOCTOBER 28, 2016 • VOLUME 291 • NUMBER 44

ously (7). Briefly, the sequences of PilA from A. baumannii
ACICU and A. nosocomialis M2, starting with alanine 23, were
cloned into a maltose-binding protein fusion vector, making
use of surface entropy reduction mutations (pMal E) described
previously (44). A C-terminal His6 tag was included for ease of
purification. These clones were transformed, expressed, and
purified as described above.
Structure Determination and Refinement—All MBP fusion
proteins were initially screened by sitting drop vapor diffusion
at a concentration of 20 mg/ml in 20 mM Bis-Tris, pH 6.0, 50
mM maltose.
MBP-PilAACICU—MBP-PilAACICU was initially crystallized
in the Hampton Research Index screen, condition D6: 0.1 M
Bis-Tris, pH 5.5, 25% (w/v) polyethylene glycol 3350. These
conditions were optimized to 0.1 M Bis-Tris, pH 5.5, 22.5%
(w/v) polyethylene glycol 3000, 0.3 M 1,6-hexanediol, 5 mM maltotriose in place of maltose. Crystals were grown in sitting
drops at room temperature and took ⬃48 h to grow at a protein
concentration of 5 mg/ml. They were then harvested and flash
cooled in the mother liquor supplemented with 20% glycerol.
Data were collected at the Stanford Radiation Source, the
National Light Source beam line X25 in Brookhaven, NY, and
eventually the data set used to resolve the structure was collected at the Advanced Photon Source, General Medical Sciences and Cancer Institutes Structural Biology Facility, beam
line 23-ID-D.
MBP-PilABIDMC57—MBP-PilABIDMC57 was initially crystallized in the Molecular Dimensions Morpheus screen, condition
A12: 0.1 M Bicine/Trizma (Tris base), pH 8.5, 12.5% (w/v) PEG
1000, 12.5% (w/v) PEG 3350, 12.5% (v/v) MPD, 0.03 M CaCl2,
0.03 M MgCl2. The optimal conditions were 0.1 M Bicine/
Trizma, pH 8.0, 12.5% (w/v) PEG 1000, 12.5% (w/v) PEG 3350,
12.5% (v/v) MPD, 0.06 M CaCl2, 0.06 M MgCl2, 50 mM NaCl, 3%
EtOH. Crystals were grown in hanging drops at room temperature and took ⬃72 h to grow at a protein concentration of 10
mg/ml. They were then harvested and flash cooled in the
mother liquor supplemented with 20% glycerol. Data were collected at the Stanford Synchrotron Radiation Lightsource,
beam line 12-2.
MBP-PilAM2—MBP-PilAM2 was initially crystallized in the
Molecular Dimensions Morpheus screen, condition A12: 0.1 M
Bicine/Trizma base, pH 8.5, 12.5% (w/v) PEG 1000, 12.5% (w/v)
PEG 3350, 12.5% (v/v) MPD, 0.03 M CaCl2, 0.03 M MgCl2. The
optimal conditions were 0.1 M Bicine/Trizma, pH 8.0, 12.5%
(w/v) PEG 1000, 12.5% (w/v) PEG 3350, 12.5% (v/v) MPD, 0.06
M CaCl2, 0.06 M MgCl2. Crystals were grown in sitting drops at
room temperature and took ⬃72 h to grow at a protein concentration of 10 mg/ml. They were then harvested and flash cooled
in the mother liquor supplemented with 20% glycerol. Data
were collected at the Advanced Photon Source, GM/CA, beam
line 23-ID-B.
The ACICU and M2 data sets were processed with XDS (45);
the BIDMC 57 data set was processed with HKL2000 (46).
Molecular replacement was carried out by Phaser (47) using a
sequential search of 1) maltose-binding protein and 2) PilA
from P. aeruginosa strain K (PAK). Phenix and Coot were
used for phasing, building, and refinement (48 –51). The
JOURNAL OF BIOLOGICAL CHEMISTRY
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crystallographic parameters of the refined data are summarized in Table 1.
Differential Scanning Fluorometry—Melting curves for pilin
headgroups were obtained by the addition of SYPRO Orange
protein stain (Sigma-Aldrich) and thermal denaturation in an
iQ5 RT-PCR cycler. The buffer conditions were 10 mM NaPO4,
150 mM NaCl, 25 mM DTT. All measurements were made in
triplicate. The resulting curves were normalized and fit using
the Boltzmann equation to determine the melting temperature
for each protein. Similar Tm values were obtained by circular
dichroism (supplemental Fig. 6) (6, 52).
Pilus Modeling—Full-length PilAACICU and PilAM2 were
modeled based on the structure of the full-length PAK pilin
(53). The initial models of the pili were created by superimposition onto a model of the Neisseria gonorrhoeae type IV pilus
filament (Protein Data Bank code 2HIL) (54), and the N-terminal helix position was adjusted to eliminate clashes between
subunits. The resulting models were then minimized as rigid
bodies using UCSF Chimera (55).
Glycan Modeling—The glycans attached to PilAACICU and
PilAM2 (supplemental Fig. 2) were modeled using the PyRosetta
protein structural modeling suite (56) with extensions for nonprotein polymer units for the glycans (57). The initial models
were generated in the Discovery Studio Visualizer (BIOVIA,
Discovery Studio Modeling Environment, Release 4.5, 2015,
Dassault Systèmes, San Diego, CA). Then the glycans were
modeled using the FloppyTail algorithm (58) altered for use in
glycans. The protocol consists of two parts. In the low resolution part, a random perturbation of the torsion angles was
applied. The high resolution parts of the structures were refined
by applying a smaller perturbation of the torsion angles, sidechain packing, and minimization. With this protocol, 6000
structures of PilAACICU and 6000 structures of PilAM2 were
generated.
Surface Area Calculations—The 10 best scoring models were
used for surface area calculations for each pilus. Exposed surface areas for pilins with and without glycans were calculated
using the pilus and glycan models described above and the
AreaIMol module of CCP4 (59) using a 1-nm spherical probe.
C-terminal glycosylation reduces the exposed surface area from
3078 to 1801 Å (PilAACICU) and from 2938 to 2218 Å (PilAM2).
Cell Adhesion—A549 human airway adenocarcinoma cells
(52) (CCL 185, American Type Culture Collection (ATCC),
Manassas, VA) or Detroit 562 pharyngeal carcinoma cells (53)
(ATCC CCL 138) were seeded in 24-well culture plates and
cultured at 37 °C in 5% CO2 to 2.0 ⫻ 105 cells/well in Dulbecco’s
modified Eagle’s medium containing 10% fetal bovine serum,
2.0 mM glutamine, 100 units/ml penicillin, and 100 g/ml
streptomycin. The cells were washed twice with PBS, pH 7.2;
fixed for 10 min at room temperature with 2.5% (v/v) glutaraldehyde in PBS, pH 7.2; and washed three times with PBS, pH 7.2
as described (60, 61). A. nosocomialis M2 was cultured overnight in Luria-Bertani broth; washed twice with PBS, pH 7.2;
resuspended in PBS, pH 7.2 containing 2.0 mg/ml glucose; and
quantified spectrophotometrically at A600. Fixed A549 or
Detroit 562 cells (2.0 ⫻ 105/well) were incubated with 2.0 ⫻ 107
colony-forming units (cfu)/well A. nosocomialis M2 in 0.5 ml
for 40 min at 37 °C and washed three times with PBS, pH 7.2.
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Bound bacteria were released with 0.05% trypsin, EDTA, and
bound cfu were quantified on Luria-Bertani agar plates as
described (60, 61). Significance was determined by Student’s t
test.
Figures—All depictions of protein structures were created
using PyMOL (Schrödinger LLC) or UCSF Chimera (55).
Sequence logos were created using WebLogo 3.4.

Results
Acinetobacter Species Produce Type IV Pilins with Diverse C
Termini—Although all strains of Acinetobacter carry the genes
necessary to produce type IV pili, and the majority of those
genes are highly conserved, the protein sequence of the major
pilin, PilA, exhibits considerable variation in the soluble
domain. In addition to this variation in amino acid sequence,
Harding et al. (38) noted that strains from multiple Acinetobacter species with a serine residue at the C terminus of the major
pilin also expressed an O-OTase similar to TfpO/PilO O-OTase
from P. aeruginosa in addition to the PglL-like O-OTase found
in all Acinetobacter strains. Analysis of pilA in 49 publically
available A. baumannii genomes, 25 with a tfpO-like O-oligosaccharyltransferase gene immediately after pilA and 24 without, shows considerable variation in both groups. All 25 tfpO⫹
strains also have pilA genes with C-terminal serine residues.
Fig. 1 shows dendrograms of PilA sequences for each of the
four Acinetobacter species in the Acb complex. Those strains
that contain a tfpO gene and end their PilA sequence with a
serine residue are marked with an asterisk to indicate putative
glycosylation at the C terminus. In A. baumannii, the majority
of these strains can be divided into two large clusters. The first
(highlighted in orange) corresponds to the international clone
II group, which is responsible for 50% of hospital infections
worldwide (62). The second cluster (highlighted in blue) contains the type strain ATCC 19606. The largest cluster of tfpO⫺
strains includes the international clone I group. Importantly,
representatives of these two clusters can be found in each of the
other members of the Acb complex. In particular, PilA proteins
from A. baumannii PilABIDMC57 and A. nosocomialis PilAM2
are highlighted because their nucleotide sequences are over
99% identical.
To better understand why such diversity exists in the type IV
pili of A. baumannii, we resolved high resolution structures of
PilA proteins representative of these two major clusters. From
the largest cluster, A. baumannii ACICU (also known as H34) is
an epidemic, multidrug-resistant strain belonging to the European clone II group that was isolated in an outbreak in Rome in
2005 (63). From the other large cluster, A. baumannii BIDMC
57 was isolated in 2013 at Beth Israel Deaconess Medical Center
(Boston, MA) and sequenced at the Broad Institute (Cambridge, MA), and A. nosocomialis M2 (referred to as A. baumannii M2 in some earlier publications) (33, 64, 65) was isolated in 1996 from a hip infection of a patient at Cleveland
MetroHealth Systems (Cleveland, OH).
High Resolution Structure of PilAACICU—We determined the
x-ray crystal structure of PilA from A. baumannii ACICU as a
C-terminal fusion to maltose-binding protein to a resolution of
2.0 Å (Table 1). As depicted in Fig. 2, the overall fold of PilAACICU
is very similar (r.m.s.d. ⫽ 2.19 Å) to PilA from PAK, differVOLUME 291 • NUMBER 44 • OCTOBER 28, 2016
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FIGURE 1. Dendrogram of Acinetobacter PilA. Dendrograms of PilA from A. baumannii, A. nosocomialis, A. calcoaceticus, and A. pittii are shown. Highlighted
in orange are strains similar to PilAACICU, and highlighted in blue are those similar to PilABIDMC57. Strains with a gene homologous to tfpO following their pilA gene
and a C-terminal serine in PilA are marked with an asterisk.

TABLE 1
Crystallographic parameters
Values in parentheses are for the highest resolution shell. r.m.s., root mean square. CC, correlation coefficient; CC1/2, Pearson correlation coefficient between half-datasets.
Resolution range (Å)
Space group
Unit cell (Å)
Total reflections
Unique reflections
Multiplicity
Completeness (%)
Mean I/(I)
Wilson B-factor
Rmerge
Rmeas
CC1/2
CC*
Rwork
Rfree
r.m.s. (bonds)
r.m.s. (angles)
Ramachandran favored (%)
Ramachandran allowed (%)
Ramachandran outliers (%)
Clashscore
Average B-factor
Macromolecules
Ligands
Solvent

MBP- PilAACICU

MBP-PilABIDMC57

MBP-PilAM2

41.02–1.975 (2.046–1.975)
P 1 21 1
41.018, 128.3, 92.505, 90, 90, 90
105,740 (2,931)
53,305 (1,577)
2.0 (1.9)
79.68 (23.63)
12.43 (2.50)
19.31
0.04968 (0.6135)
0.07026
0.992 (0.184)
0.998 (0.558)
0.1807 (0.2635)
0.2408 (0.3457)
0.008
1.09
98
2
0
5.03
26.3
25.9
19.7
30.6

43.93–2.2 (2.279–2.2)
C121
175.07, 56.636, 49.997, 90, 91.6, 90
125,933 (5,583)
23,793 (2,036)
5.3 (2.7)
94.85 (82.26)
11.1 (1.70)
35.78
0.341 (1.10)
0.375
0.966 (0.314)
0.991 (0.691)
0.2109 (0.2950)
0.2440 (0.3336)
0.013
1.33
97
2
0.62
2.43
28.10
27.30
53.10
41.90

29.44–1.801 (1.865–1.801)
C121
173.883, 55.334, 49.67, 90, 91.52, 90
150,644 (8,909)
42,472 (3,492)
3.5 (2.6)
96.82 (79.43)
14.90 (1.77)
27.29
0.05086 (0.5152)
0.06005
0.998 (0.791)
1 (0.94)
0.1889 (0.3638)
0.2280 (0.3943)
0.008
1.18
96
1
0.83
9.08
37.1
37
34.1
40.20

ing primarily in the ␣␤-loop (the loop beginning with the end of
the initial ␣-helix and ending with the beginning of the first
␤-strand) (53). Among the differences between PilA from PAK
and from ACICU are the ␣-helical character of the ACICU
OCTOBER 28, 2016 • VOLUME 291 • NUMBER 44

␣␤-loop and the longer length of the loop between the third and
fourth strands of the central ␤-sheet. Combined, these features
give PilAACICU an axis of pseudosymmetry running diagonally
across the molecule from the helix in the ␣␤-loop to the small
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Structure of PilAACICU. A, schematic representation of PilAACICU beginning with alanine 23. B, superimposition of PilAACICU (gold) with PilAPAK (gray);
the inset panels show the two regions containing disulfide bonds in PilAACICU.

helical region in the C terminus, a feature also found in the
structure of PilA from P. aeruginosa K122-4 (66). Notably, contacts between pilin headgroups in a pilus typically occur primarily between these same regions of the protein (2).
PilAACICU contains two disulfide bonds. One, between residues 123 and 136, is analogous to the C-terminal disulfide bond
also found in PilAPAK, which is nearly universal in type IV pili
from Gram-negative bacteria. The other, between residues 74
and 91, spans the first two strands of the central ␤-sheet (Fig.
2B). However, we note that this additional disulfide bond in
PilAACICU (relative to PilAPAK) does not result in any substantial rearrangement of the protein backbone.
High Resolution Structures of PilABIDMC57 and PilAM2—
Although all Acinetobacter PilA sequences are nearly identical
in the N-terminal hydrophobic ␣-helix, they diverge substantially beyond that point (e.g. PilAACICU and PilABIDMC57 are
35% identical from alanine 23 onward). However, the sequence
variability of type IV pilins is such that homologs sharing only
30 – 40% sequence identity commonly have strikingly similar
folds (the headgroups of PilAPAK and PilAACICU are 30% identical in sequence). To determine whether those pilins from the
type strain cluster represented a distinct fold from those
from the predominant international clone II cluster, we determined the x-ray crystal structures of PilA from A. baumannii
BIDMC 57 and A. nosocomialis M2 as C-terminal fusions to
MBP to resolutions of 2.2 and 1.8 Å, respectively (Table 1).
Although retaining the typical type IV pilin fold, the structure of PilABIDMC57 differs notably from that of PilAACICU and
PilAPAK with its fold showing somewhat of an inversion along
the previously described axis of pseudosymmetry (Fig. 3A), possessing an ␣-helix at the C terminus rather than the N terminus.
The PilABIDMC57 ␣␤-loop contains 1) a short ␤-strand rather
than an ␣-helix at its C terminus and 2) a seven-residue ␣-helix
not found in PilAACICU. This rearrangement results in the C
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terminus of PilABIDMC57 being shifted 13 Å relative to PilAACICU
when the two pilin headgroups are superimposed (Fig. 3D).
Although there are few prior examples of multiple high resolution structures being solved from a single species, this degree of
structural variation (r.m.s.d. ⫽ 4.17 Å) is greater than is
expected within a given species. All three known structures of
Clostridium difficile PilA1 are within 1-Å r.m.s.d. of each other
(7), and PilAPAK and PilAK122-4 from P. aeruginosa are within 2
Å r.m.s.d. of each other and have superimposable C termini (53,
66). As expected from their sequence identity of over 99%,
A. baumannii PilABIDMC57 and A. nosocomialis PilAM2 have
nearly identical structures as well, differing only in conformations of the ␣␤-loop and the loop between the fourth and fifth
␤-strands (Fig. 3B).
Structural Implications for PilABIDMC57 and PilAACICU
Assembly—Of all the component proteins of a type IV pilus
system, including major and minor pilins, extension and retraction ATPases, and other pilus biogenesis machinery, the major
pilin protein is always the least conserved within a given species. However, the major pilin must retain the ability to assemble into a pilus, slowing the rate of variation in regions involved
in intersubunit interactions. Although in some species the
sequence variability of the major pilin is confined to hypervariable regions that are solvent-exposed in the assembled pilus
(14), only the hydrophobic ␣1-N helix is well conserved in
A. baumannii PilA (Fig. 3C). To understand how surface polymorphisms in PilA might impact pilin polymerization, we created models of A. baumannii pilus fibers from PilAACICU and
PilABIDMC57 based on the N. gonorrhoeae pilus (54) and compared the interactions between the pilin headgroups. Despite a
sequence identify of only 35% between the PilAACICU and
PilABIDMC57 proteins (residues 23–136), many chemical moieties can be found in similar positions (Fig. 3D). These relationships are not obvious from a sequence alignment of the two
VOLUME 291 • NUMBER 44 • OCTOBER 28, 2016
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FIGURE 3. Structure of PilABIDMC57. A, schematic representation of PilABIDMC57 beginning with alanine 23. B, superimposition of PilABIDMC57 (dark blue) with
PilAM2 (light blue) and FimA (gray). C, sequence alignment of PilAACICU and PilABIDMC57; conservation of amino acid sequence in PilA across A. baumannii (Ab)
from a global alignment is indicated below. D, superimposition of PilAACICU (gold) and PilABIDMC57 (blue).

protein sequences (Fig. 3C) but become clear upon superimposition of the two structures. One implication of these data is
that despite their divergence in sequence the major pilins of the
various Acinetobacter strains may be assembled through similar networks of non-covalent interactions.
Type IV Pili Promote Adhesion to A549 Cells—The resemblance of A. baumannii type IV pili to other type IVa pilus systems (particularly P. aeruginosa and D. nodosus) led us to
hypothesize that they may have overlapping functions. Previously, Acinetobacter type IV pili have been shown to be essential for natural transformation and twitching motility, but few
data are available about their roles in infection-associated processes such as adherence to host cells or biofilm formation. To
determine whether type IV pili play a role in bacterial host-cell
adhesion, we measured the ability of wild type A. nosocomialis
M2 and mutants with altered type IV pili biogenesis phenotypes
to bind to immortalized lung (A549) and nasopharyngeal
(Detroit 562) epithelial cells in vitro. We found that the ⌬pilA
strain, which produces no type IV pili, exhibited reduced adhesion to A549 cells in vitro and that wild type adhesion was
restored after complementation with the wild type pilA gene
(Fig. 4). To probe the importance of C-terminal glycosylation in
this process, we also tested a ⌬pilA strain complemented with
pilA point mutant S136A, which cannot be glycosylated. Wild
type PilA and PilA(S136A) are equally capable of complementing the adhesion defect of the ⌬pilA mutant strain, indicating
that pilin glycosylation plays no significant role in host cell
adhesion. Increased binding by the ⌬pilT mutant of M2, which
is known to be hyperpiliated (33, 65), shows both that increased
piliation increases adhesion and that the ability to retract type
IV pili is not a component of type IV pilus-mediated bacterial
host-cell adhesion. We found that universally M2 binds Detroit
OCTOBER 28, 2016 • VOLUME 291 • NUMBER 44

FIGURE 4. Acinetobacter nosocomialis M2 adherence to host cells. The
average number of colony-forming units of A. nosocomialis recovered from a
binding experiment with either A549 cells (black) or Detroit 562 cells (gray) is
shown. Significance is marked as follows: *, p ⬍ 0.05; ***, p ⬍ 0.001. Error bars
represent S.D.

562 cells much more weakly than A549 cells with only the ⌬pilT
strain showing any adhesion above background; this finding is
similar to several strains tested by Eijkelkamp et al. (36). We
also tested the ability of A. nosocomialis M2 to form a biofilm in
vitro and found no significant difference among the wild type
strain, the ⌬pilA mutant, and the complemented mutant (supplemental Fig. 1).
C-terminal Glycans Mask the PilA Protein in Models of Pilus
Assembly—There are four canonical functions for type IV pili:
(i) twitching motility, (ii) horizontal gene transfer, (iii) host cell
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 5. Models of glycosylated Acinetobacter type IV pili. Models of
assembled type IV pili from A. baumannii ACICU (orange) and A. nosocomialis
M2 (blue) are depicted with semitransparent surfaces; glycan residues are
shown in gray. Inset panels show detail of the top 10 computed glycan conformations. The percentages note the change in surface area exposed to a
10-Å probe for each pilin monomer upon addition of the C-terminal glycan
cloud.

adhesion, and (iv) bacterial self-association (biofilm formation).
As described above, none of these functions are dependent on
C-terminal glycosylation of the major pilin in Acinetobacter in
vitro. However, previous studies of C-terminal glycosylation in
the major pilin of P. aeruginosa 1244 demonstrated a significant
phenotype in vivo. Smedley et al. (21) demonstrated that deletion of the O-oligosaccharyltransferase tfpO (referred to by the
authors as pilO) reduced survival of P. aeruginosa 1244 in a
mouse model of lung infection. More recently, the P. aeruginosa 1244 ⌬tfpO mutant was found to be more vulnerable to
phagocytosis mediated by opsonization (67, 68).
Because opsonization is mediated by the binding of host
immune proteins (commonly antibodies), the latter studies
support the notion that the purpose of C-terminal glycosylation
could be to interfere with immune recognition in vivo. Similarly, Gault et al. (25) recently showed that hypervirulent
N. meningitidis strains with class II pilins are more heavily glycosylated than their class I counterparts.
To measure the extent to which C-terminal glycosylation of
PilAACICU and PilAM2 would mask the pilin protein from binding, we modeled the full-length pilins and pilus fibers and measured the effect of glycosylation on the accessible surface area of
each protein in its native context. We modeled an ensemble of
each glycan based on the repeating unit of the major polysaccharide glycan and minimized each structure using Rosetta
(69). The 10 best scoring glycan conformations were then combined to approximate the native conformational ensemble.
We then measured the differences in accessible surface area
using a 10-Å particle probe to approximate the surface area
needed for protein binding. The resulting models are shown in
Fig. 5, and the change in accessible surface area for each protein
is displayed in the inset panel. In both cases, C-terminal
glycosylation reduces the exposed surface area (by 42% for
PilAACICU and by 25% for PilAM2). The greater coverage of
the PilAACICU protein stems from the greater flexibility of the
linear PilAACICU glycan (in contrast to the branched PilAM2
glycan) (supplemental Fig. 2), which results in a more diverse
conformational ensemble.
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If C-terminal glycosylation in Acinetobacter type IV pili
reduces recognition by host immune proteins, one might
expect that the pilins from strains lacking a C-terminal glycan
would face greater pressure to diversify as has been shown in
N. meningitidis (25). Using our alignment of 49 PilA sequences,
we separated protein sequences into tfpO⫺ and tfpO⫹ groups
and compared the variability of their surface-exposed residues.
For the tfpO⫺ group, we modeled the structure of PilAAYE
(an international clone I strain) based on the structure of
PilAACICU. Supplemental Fig. 3A shows that, although overall
the surface residue variability follows a similar pattern in the
two groups, there is a region near the C terminus that is more
conserved in the tfpO⫹ strains. Supplemental Fig. 3B shows
sequence logos of this region for both groups. These data support a model in which C-terminal glycosylation in type IV pili
exists, at least in part, as a countermeasure to the host humoral
immune response.
Variation in Acinetobacter pilA Is Driven by Evolutionary
Pressure—To understand the basis for the structural resemblance of PilAACICU and PilABIDMC57 of A. baumannii to
P. aeruginosa PilAPAK and D. nodosus FimA, respectively, we
compared nucleotide and amino acid sequences for the major
pilin from 11 representative genomes from each of the three
species (Fig. 6). To evaluate the possibility that the cross-species
similarities in pilA arose from horizontal gene transfer, we
aligned the sequences of 54 nucleotides encoding the first 18
residues of the mature protein product, which is identical
(FTLIELMIVVAIIGILAA) in all 33 amino acid sequences.
Fig. 6A shows that, based on silent variations in these nucleotide sequences, the pilin genes can be separated neatly into
three clusters based on species. That is, despite their dissimilarity in amino acid sequence, the nucleotide sequences for the
␣1-N domain of pilAACICU and pilABIDMC57 more closely
resemble each other than their equivalents from P. aeruginosa
and D. nodosus. However, when mature PilA amino acid
sequences are aligned, all three of the resulting clusters contain
representatives from multiple sequences. As they are labeled in
Fig. 6B, cluster I contains the majority of the D. nodosus FimA
serotypes (including serotype A, the sequence of Protein Data
Bank code 3SOK) as well as A. baumannii PilABIDMC57 and
ATCC 19606
PilA
. Cluster II contains PilAACICU as well as P. aeruginosa PilAPAK and PilAPAO1. Cluster III consists of two FimA
sequences that contain C-terminal disulfide bonds, A. baumannii PilA135867 and PilA121738, and the P. aeruginosa PilA
sequences with C-terminal serine residues.
The A. baumannii sequences from each of the three clusters
are shown in Fig. 6C. Cluster II contains species from the international clone I group, whereas cluster III contains species from
the international clone II group. Cysteine residues are highlighted in yellow and indicate differential disulfide bonding patterns between the three clusters; cluster III PilA sequences contain two disulfide bonds, and the majority of cluster I sequences
do not contain a disulfide bond at the C terminus. However, all
sequences in cluster I, from both Acinetobacter and Dichelobacter, contain hydrophobic residues aligned to isoleucine 106
and leucine 129 (highlighted in violet). These data support the
hypothesis that variation in Acinetobacter pilA is the result of
common evolutionary pressures that are common to A. bauVOLUME 291 • NUMBER 44 • OCTOBER 28, 2016
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FIGURE 6. Divergent evolution of Acinetobacter PilA. A, dendrogram of the nucleotide sequence of the a1-N helix. Sequences from A. baumannii are
highlighted in green, D. nodosus is in blue, and P. aeruginosa is in orange. B, dendrogram of the pilin amino acid sequence; sequences are colored identically to
A. C, comparison of the three branches of A. baumannii PilA. Cysteine residues are highlighted in yellow, and the conserved C-terminal hydrophobic residues
in cluster I are highlighted in violet.

mannii BIDMC 57 and D. nodosus (serotype A) and conversely
A. baumannii ACICU and P. aeruginosa PAK but not to
A. baumannii as a whole, resulting in a structural divergence
of A. baumannii PilA.
Hydrophobic Interactions Stabilize the PilAM2 C Terminus—
One notable aspect of the PilABIDMC57 and PilAM2 structures is
that, unlike PilAACICU, they contain only a single disulfide bond
between residues 56 and 86 in the ␣␤-loop and the first strand
of the ␤-sheet, respectively, rather than a disulfide bond at the C
terminus of the pilin headgroup (Fig. 7A). The addition of covalent disulfide bonds is typically understood to be a mechanism
of stabilization in polypeptides, and hence the C-terminal disulfide bond, which is nearly ubiquitous in type IV pilins, is
thought to be conserved to stabilize the pilin fold (3).
However, the lack of a C-terminal disulfide bond is not
unique to Acinetobacter and, in fact, was observed previously
in the structure of FimA from D. nodosus (serotype A) that
PilABIDMC57 and PilAM2 closely resemble (Fig. 7B). The principal difference between the two folds is that the shorter loops of
Acinetobacter PilABIDMC57 and PilAM2 result in a more compact structure. The lone disulfide bond in PilABIDMC57 and
PilAM2 is found in a position identical to the disulfide bond in
FimA and the N-terminal disulfide bond in PilAK122-4 (Fig. 7A).
As PilABIDMC57, PilAM2, and FimA have such similar folds and
both lack a disulfide bond at the C terminus, we compared the
structures of their C termini for common structural features
that might explain the absence of a C-terminal disulfide bond.
Because D. nodosus is an obligate anaerobe and cysteine residues are more likely to be reduced in anaerobic environments,
one explanation for the structural convergence of PilAM2 and
FimA (serotype A) is that they use pilin folds, which are less
reliant on a C-terminal disulfide bond for stability.
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Hartung et al. (70) noted three non-covalent interactions in
FimA that are in a similar position to the disulfide bond found
in other pilins from Gram-negative bacteria: a backbone hydrogen bond between tyrosine 133 and valine 149, a hydrogen bond
between the lysine 132 side chain and the backbone oxygen of
lysine 150, and a van der Waals interaction between the tyrosine 133 phenyl ring and the aliphatic portion of the lysine 150
side chain. As no equivalents to these interactions can be found
in the PilABIDMC57 and PilAM2 structures, we turned our attention to potentially stabilizing interactions between pairs of aliphatic side chains. In FimA, leucine 124, leucine 140, leucine
142, and isoleucine 145 can potentially form several such pairs,
and several would be superimposable with those formed by
isoleucine 106, valine 126, leucine 129, and valine 134 in PilAM2
and PilABIDMC57 (Fig. 7B).
As noted above, this pattern is conserved in all 14 sequences
in cluster I with two of these positions, Ile-106 and Leu-129,
being universally isoleucine, leucine, or valine. Conversely,
although Ile-106 is conserved in PilAACICU, the other three
positions are occupied by glutamate, arginine, and glycine.
To test our hypothesis that solvent exclusion from these aliphatic contacts stabilized PilAM2 in place of the canonical
C-terminal disulfide bond, we measured the thermal stability of
the PilAACICU and PilAM2 headgroups as well as a PilAM2
mutant with these four hydrophobic side chains truncated
(I106A,V126A,L129A,V134A) using differential scanning fluorometry (Fig. 7C) (71). We found that although the wild
type PilAM2 (Tm ⫽ 51.7 ⫾ 0.2 °C) was less thermostable than
PilAACICU (Tm ⫽ 55.7 °C ⫾ 0.1), the hydrophobic C terminus of
PilAM2 did contribute to the stability of the fold as evidenced by
the lower melting temperature of the alanine mutant (Tm ⫽
45.0 ⫾ 0.5 °C).
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FIGURE 7. Hydrophobic interactions in the PilAM2 C terminus. A, schematic representations of various major pilins; disulfide bonds are marked with yellow
spheres. B, superimposition of PilAM2 (blue) and FimA (gray); an inset panel shows the C-terminal region where a disulfide bond is typically found in type IV pilins.
C, differential scanning fluorometry curves showing stability measurements for PilAACICU, PilAM2, and PilAM2(I106A,V126A,L129A,V134A).

Discussion
From an evolutionary standpoint, the x-ray crystal structures
reported here pose three questions for us. Why have the major
pilins of A. baumannii diverged? Why are some, but not all,
PilA proteins C-terminally glycosylated? And why do the major
pilins from A. baumannii ACICU and BIDMC 57 resemble
their counterparts from other bacterial species (P. aeruginosa
and D. nodosus, respectively) more closely than they do each
other?
The presence of close homologs to both PilAACICU and
PilABIDMC57 in all four species that make up the Acb complex
strongly implies that the divergence in pilA predates the divergence of A. baumannii and A. nosocomialis. This, combined
with the similarities between PilAACICU and PilAPAK and
between PilABIDMC57 and FimA (serotype A), suggest that the
divergence in Acinetobacter pilA is not due to functionally neutral diversifying selection, as is thought to be the case in Neisseria pilE, but instead due to functionally divergent evolution.
Determining which selective pressures favor a PilAACICU/
PilAPAK-like structure over that of PilABIDMC57 and FimA (or
vice versa) is more difficult, but possibilities include altered
binding specificity and stability under different environmental
conditions. We note that both Acinetobacter and Pseudomonas
inhabit a wide range of environments and that both genera as
well as Dichelobacter can be isolated from soil. Differing types
of soil or solid surfaces may favor one structure over another.
Another possibility is that some Acinetobacter type IV pilus
systems are optimized for one function (horizontal gene transfer, twitching motility, or adherence) over another. Direct comparisons of twitching motility between A. nosocomialis M2
(cluster I) and A. baumannii ATCC 17978 (cluster III) do show
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somewhat greater motility for M2 (supplemental Fig. 4), but
this complex process is impacted by many factors in addition to
the sequence, structure, and function of PilA.
The related question of why Acinetobacter pilA genes have
diverged into glycosylated and non-glycosylated forms is complicated by the fact that no functional gain or defect has been
attributed to the C-terminal glycan in Acinetobacter, and both
tfpO⫺ and tfpO⫹ strains have been shown to be infectious (72,
73). Similar results were obtained for the ⌬tfpO mutant of
P. aeruginosa 1244, which was also found to be equally susceptible to phage attachment (21). Also arguing against a functional role for C-terminal glycans is the lack of correlation
between polysaccharide and polypeptide composition; for
example, PilA proteins from A. baumannii ATCC 19606 and
A. nosocomialis M2 are 93% identical, but the major polysaccharide glycans from these strains are completely unrelated
(supplemental Fig. 5) (38, 74). Taken together, these findings
imply that even gross alterations to the exposed surface of the
major pilin have little functional impact and suggest that some
or all of these binding events may occur not through the major
pilin but rather through the minor pilins.
It was this lack of observable phenotype that led us to search
for alternative explanations for the prevalence of tfpO-mediated glycosylation in Acinetobacter. Previous work in P. aeruginosa 1244, demonstrating that a ⌬tfpO mutant was more vulnerable to phagocytosis mediated by opsonization (67, 68),
implied that C-terminal glycosylation formed an obstacle to
binding by host immune proteins. Our quantification of the
ability of Acinetobacter C-terminal glycans to mask their conjugate polypeptides shows that over 25% of the PilA surface area
available for binding is occluded. C-terminal glycosylation
VOLUME 291 • NUMBER 44 • OCTOBER 28, 2016
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should, therefore, offer an advantage provided that the glycan
surface is less vulnerable to binding by antibodies or other
opsonins.
The evolutionary distance between A. baumannii BIDMC 57
(and A. nosocomialis M2) and D. nodosus suggests that the
close resemblance between their respective pilin proteins is the
result of convergent evolution. Although the functional benefit
of this fold to the soil gammaproteobacteria found in class I of
the alignment in Fig. 6 remains to be determined, it seems
unlikely that the absence of a C-terminal disulfide bond in 12
of the 14 cluster I sequences is due to chance. We speculate
that the cluster I fold may be advantageous in an anaerobic
environment.
A further implication of the diversity in Acinetobacter type
IV pilins is the challenge it poses for vaccine development.
Because of their abundance in the extracellular space, type IV
pili are obvious candidates for subunit vaccines and have been
successfully used as such for other bacteria, including D. nodosus (75, 76). However, in Acinetobacter, the combination of variability in the PilA polypeptide with variation in polysaccharide
structure in many strains may present a significant barrier to
inducing a robust and durable immune response.
In conclusion, the results presented here reveal that type IV
pili in Acinetobacter have diverged in a manner unrelated to the
genetic divergence of species within the Acb complex and that
similarities in type IV pili cross species, genus, and family lines.
These data reinforce the principle that functional requirements
determine protein structure while allowing considerable variation in sequence. These data also imply that three distinct functional classes of type IV pili exist in Acinetobacter and other soil
gammaproteobacteria.
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